Cross Country Healthcare — one of the largest travel nursing staffing firms in the US — agreed Wednesday to be taken private by private equity firm Knox Lane in an all-cash deal valued at $437 million. The acquisition, announced May 6 and confirmed via regulatory filings, values Cross Country shares at $13.25 each — a 31% premium over the closing price the day before the deal was announced.
For travel nurses, the short answer is: nothing changes right now. Cross Country confirmed it will continue operating under its existing brand, maintaining its Intellify platform and all current staffing programs. But private equity ownership of a major staffing firm introduces a variable that travel nurses should track over the next few years.
Why This Deal Happened
Cross Country had been in play for months. An earlier deal with Aya Healthcare — which would have combined the two largest travel nursing firms — collapsed in 2025 after FTC antitrust scrutiny. The Knox Lane transaction is cleaner because Knox Lane is a financial buyer with no existing staffing operations, so there's no competitive overlap to review.
Cross Country posted revenue around $1.3 billion in its most recent full year, down significantly from the COVID-era peak when travel nursing rates hit $4,000–$6,000/week across ICU specialties. The company employs tens of thousands of travel nurses and allied health professionals annually across hospital, long-term care, and school health settings.
What PE Ownership Means for Travel Nurses
Private equity firms buy staffing companies to improve margins — typically through technology investment, geographic expansion, or operating cost reduction. The concern for travel nurses is whether "operating cost reduction" eventually means suppressed pay rates, reduced benefits, or changes to housing stipend structures.
The more optimistic read: Knox Lane buys companies to grow them, not gut them. Their track record in healthcare services has been acquisitive expansion rather than cost-cut-and-exit. Cross Country's Intellify platform — a tech layer that manages staffing logistics across healthcare systems — is likely the primary asset Knox Lane is buying, and growth in that platform requires a functional nurse supply chain to run on.
What to watch: contract terms over the next 12–18 months. If pay packages compress at Cross Country while competitor agencies maintain rates, that's a signal. If the platform capabilities improve and nurses get faster placements and more transparent contract data, it worked the other way. The leverage is always in having multiple agency relationships — use it.
Background: The Failed Aya Merger
This deal comes about a year after Cross Country and Aya Healthcare abandoned their merger plans under FTC antitrust scrutiny. That deal would have combined the two largest travel nursing firms in the US, and regulators concluded it would harm competition in healthcare staffing. The Knox Lane transaction avoids that concern entirely — Knox Lane is a financial buyer, not a staffing competitor. Regulators are unlikely to raise the same objections, and the deal is expected to close in Q3 2026 pending shareholder vote and routine regulatory clearance.
Cross Country will continue trading under its existing brand and platform after the acquisition closes. Nurses currently on assignment through Cross Country will not see immediate changes to their contracts or placements.
What Travel Nurses Should Do Now
Nothing about your current contract or placement is changing. Cross Country will operate as before through the close in Q3 2026, and likely well beyond. However, this is a good moment to review a few things regardless of agency:
First, verify you have signed copies of your current contract including the compensation breakdown. Stipend structures, housing per diems, and completion bonuses can change between contract renewals — not necessarily because of ownership changes, but because market conditions shift. Having a baseline to compare against matters.
Second, if you are not already using a pay calculator to verify your gross weekly equivalent against what the agency is offering, start now. The gap between posted bill rates and what nurses receive as take-home has historically varied significantly across agencies, and a PE-owned firm has additional margin pressure to manage.
Third, keep 2–3 agency relationships active. This is standard advice that predates the acquisition — but PE ownership is one more reason to have optionality. Competition between agencies is your primary lever for better contract terms.
In 12+ years of travel nursing across multiple agencies, the single most consistent piece of advice I give new travel nurses is: never rely on one agency. A PE acquisition is exactly why. Cross Country may be completely fine. But your negotiating position depends on having alternatives. Keep your profiles active at 2–3 agencies and check Vivian or bluepipes for rate comparisons before signing anything.